Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Antisense oligonucleotide targeting the F508delta mutation of CFTR

EU orphan designation number: EU/3/13/1195   
Active ingredient: Antisense oligonucleotide targeting the F508delta mutation of CFTR
Indication: Treatment of cystic fibrosis
Sponsor: ProQR Therapeutics III BV
Zernikedreef 9, 2333 CK Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Orphan designation EMA/OD/096/13 (2013)6740 of 07/10/2013
19/01/2016 Transfer of orphan designation EMA/OD/096/13/T/01 (2016)255 of 15/01/2016
18/08/2016 Change of name and/or address of sponsor